aspirin 81

Generic: aspirin

Labeler: rising pharma holdings, inc.
NDC Directory HUMAN OTC DRUG OTC MONOGRAPH DRUG Inactive Finished

Drug Facts

Product Profile

Brand Name aspirin 81
Generic Name aspirin
Labeler rising pharma holdings, inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

aspirin 81 mg/1

Manufacturer
Rising Pharma Holdings, Inc.

Identifiers & Regulatory

Product NDC 57237-302
Product ID 57237-302_ffa0c51f-1493-4897-99cf-8ae6ab2a6f05
Product Type HUMAN OTC DRUG
Marketing Category OTC MONOGRAPH DRUG
Application Number M013.50
Listing Expiration 2026-12-31
Marketing Start 2022-10-25

Pharmacologic Class

Established (EPC)
nonsteroidal anti-inflammatory drug [epc] platelet aggregation inhibitor [epc]
Mechanism of Action
cyclooxygenase inhibitors [moa]
Chemical Structure
anti-inflammatory agents, non-steroidal [cs]
Physiologic Effect
decreased prostaglandin production [pe] decreased platelet aggregation [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 57237302
Hyphenated Format 57237-302

Supplemental Identifiers

RxCUI
308416
UNII
R16CO5Y76E
NUI
N0000000160 N0000008836 M0001335 N0000175722 N0000175578 N0000008832

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name aspirin 81 (source: ndc)
Generic Name aspirin (source: ndc)
Application Number M013.50 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 81 mg/1
source: ndc
Packaging
  • 1000 TABLET in 1 BOTTLE (57237-302-10)
  • 120 TABLET in 1 BOTTLE (57237-302-12)
source: ndc

Packages (2)

57237-302-10 1000 TABLET in 1 BOTTLE (57237-302-10) 57237-302-12 120 TABLET in 1 BOTTLE (57237-302-12)

Ingredients (1)

aspirin (81 mg/1)

Linked Drug Pages (1)

Aspirin 81 ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "ffa0c51f-1493-4897-99cf-8ae6ab2a6f05", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832"], "unii": ["R16CO5Y76E"], "rxcui": ["308416"], "spl_set_id": ["bfc4fd55-45db-41f4-b878-a6b7155f0849"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1000 TABLET in 1 BOTTLE (57237-302-10)", "package_ndc": "57237-302-10", "marketing_start_date": "20221025"}, {"sample": false, "description": "120 TABLET in 1 BOTTLE (57237-302-12)", "package_ndc": "57237-302-12", "marketing_start_date": "20221025"}], "brand_name": "Aspirin 81", "product_id": "57237-302_ffa0c51f-1493-4897-99cf-8ae6ab2a6f05", "dosage_form": "TABLET", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "product_ndc": "57237-302", "generic_name": "Aspirin", "labeler_name": "Rising Pharma Holdings, Inc.", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Aspirin 81", "active_ingredients": [{"name": "ASPIRIN", "strength": "81 mg/1"}], "application_number": "M013.50", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20221025", "listing_expiration_date": "20261231"}